Microbot Medical (MBOT) Competitors $3.37 -0.17 (-4.80%) Closing price 04:00 PM EasternExtended Trading$3.38 +0.00 (+0.15%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MBOT vs. BVS, AVNS, ZIMV, KIDS, TMCI, SMLR, CBLL, DCTH, SNWV, and BFLYShould you be buying Microbot Medical stock or one of its competitors? The main competitors of Microbot Medical include Bioventus (BVS), AVANOS MEDICAL (AVNS), ZimVie (ZIMV), OrthoPediatrics (KIDS), Treace Medical Concepts (TMCI), Semler Scientific (SMLR), CeriBell (CBLL), Delcath Systems (DCTH), Sanuwave Health (SNWV), and Butterfly Network (BFLY). These companies are all part of the "medical equipment" industry. Microbot Medical vs. Its Competitors Bioventus AVANOS MEDICAL ZimVie OrthoPediatrics Treace Medical Concepts Semler Scientific CeriBell Delcath Systems Sanuwave Health Butterfly Network Microbot Medical (NASDAQ:MBOT) and Bioventus (NASDAQ:BVS) are both small-cap medical equipment companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, risk, media sentiment, valuation, institutional ownership, profitability, analyst recommendations and dividends. Does the media favor MBOT or BVS? In the previous week, Microbot Medical had 2 more articles in the media than Bioventus. MarketBeat recorded 2 mentions for Microbot Medical and 0 mentions for Bioventus. Bioventus' average media sentiment score of 0.00 beat Microbot Medical's score of -0.12 indicating that Bioventus is being referred to more favorably in the news media. Company Overall Sentiment Microbot Medical Neutral Bioventus Neutral Is MBOT or BVS more profitable? Microbot Medical has a net margin of 0.00% compared to Bioventus' net margin of -0.03%. Bioventus' return on equity of 23.04% beat Microbot Medical's return on equity.Company Net Margins Return on Equity Return on Assets Microbot MedicalN/A -76.27% -67.54% Bioventus -0.03%23.04%6.04% Which has stronger valuation & earnings, MBOT or BVS? Microbot Medical has higher earnings, but lower revenue than Bioventus. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMicrobot MedicalN/AN/A-$11.44M-$0.58-5.81Bioventus$573.28M1.02-$33.54MN/AN/A Do institutionals & insiders hold more shares of MBOT or BVS? 16.3% of Microbot Medical shares are held by institutional investors. Comparatively, 62.9% of Bioventus shares are held by institutional investors. 4.7% of Microbot Medical shares are held by insiders. Comparatively, 33.0% of Bioventus shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Do analysts recommend MBOT or BVS? Microbot Medical presently has a consensus target price of $9.00, suggesting a potential upside of 167.06%. Given Microbot Medical's stronger consensus rating and higher possible upside, equities analysts clearly believe Microbot Medical is more favorable than Bioventus.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Microbot Medical 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Bioventus 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more volatility & risk, MBOT or BVS? Microbot Medical has a beta of 1.22, indicating that its stock price is 22% more volatile than the S&P 500. Comparatively, Bioventus has a beta of 0.84, indicating that its stock price is 16% less volatile than the S&P 500. SummaryMicrobot Medical and Bioventus tied by winning 7 of the 14 factors compared between the two stocks. Get Microbot Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for MBOT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MBOT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MBOT vs. The Competition Export to ExcelMetricMicrobot MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$161.23M$6.90B$5.76B$9.85BDividend YieldN/A1.22%6.71%4.51%P/E Ratio-5.8118.4859.1122.53Price / SalesN/A70.07547.00119.09Price / CashN/A21.6037.0558.92Price / Book19.824.9010.916.06Net Income-$11.44M$178.27M$3.29B$266.28M7 Day Performance-15.75%-0.61%0.01%-0.76%1 Month Performance27.17%1.88%7.06%3.83%1 Year Performance305.34%9.93%50.09%24.39% Microbot Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MBOTMicrobot Medical2.0293 of 5 stars$3.37-4.8%$9.00+167.1%+306.9%$161.23MN/A-5.8120BVSBioventusN/A$7.44-2.6%N/AN/A$631.67M$573.28M15.281,200AVNSAVANOS MEDICAL2.6639 of 5 stars$11.58-1.2%N/A-48.7%$543.37M$687.80M-1.152,227Positive NewsZIMVZimVie0.7302 of 5 stars$18.96+0.1%$17.75-6.4%+9.6%$534.41M$449.75M-27.091,770News CoveragePositive NewsKIDSOrthoPediatrics4.4197 of 5 stars$20.29+0.4%$34.14+68.3%-31.5%$506.49M$204.73M-11.34200Positive NewsTMCITreace Medical Concepts2.5732 of 5 stars$7.47-3.0%$9.83+31.6%+26.7%$486.43M$209.36M-9.46250Positive NewsAnalyst ForecastSMLRSemler Scientific3.4532 of 5 stars$30.02-4.5%$81.75+172.3%+17.8%$465.31M$56.29M3.74120News CoverageCBLLCeriBell2.579 of 5 stars$11.44-5.1%$32.14+181.0%N/A$442.17M$65.44M-3.83N/ADCTHDelcath Systems3.1666 of 5 stars$10.89-2.1%$24.50+125.0%+3.2%$388.99M$37.21M217.8060Positive NewsSNWVSanuwave HealthN/A$42.66-5.2%$55.00+28.9%N/A$385.56M$32.63M0.0040News CoverageAnalyst ForecastBFLYButterfly Network3.1929 of 5 stars$1.56+2.3%$3.00+92.9%+26.5%$382.65M$82.06M-5.55460Positive News Related Companies and Tools Related Companies Bioventus Alternatives AVANOS MEDICAL Alternatives ZimVie Alternatives OrthoPediatrics Alternatives Treace Medical Concepts Alternatives Semler Scientific Alternatives CeriBell Alternatives Delcath Systems Alternatives Sanuwave Health Alternatives Butterfly Network Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MBOT) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredTrump’s national nightmare is hereWashington just added $1 trillion to the national debt in less than two months — an astonishing pace of spendi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Microbot Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Microbot Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.